Stone House Investment Management LLC acquired a new stake in shares of UnitedHealth Group Inc (NYSE:UNH) during the first quarter, HoldingsChannel reports. The fund acquired 294 shares of the healthcare conglomerate’s stock, valued at approximately $73,000.

A number of other institutional investors also recently modified their holdings of UNH. Oregon Public Employees Retirement Fund lifted its position in UnitedHealth Group by 50,446.5% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 53,349,795 shares of the healthcare conglomerate’s stock valued at $214,000 after purchasing an additional 53,244,249 shares during the period. Norges Bank bought a new position in UnitedHealth Group during the fourth quarter valued at approximately $2,343,175,000. BlackRock Inc. lifted its position in UnitedHealth Group by 3.1% during the fourth quarter. BlackRock Inc. now owns 69,831,381 shares of the healthcare conglomerate’s stock valued at $17,396,391,000 after purchasing an additional 2,123,417 shares during the period. FMR LLC lifted its position in UnitedHealth Group by 1.9% during the fourth quarter. FMR LLC now owns 64,480,003 shares of the healthcare conglomerate’s stock valued at $16,063,258,000 after purchasing an additional 1,232,189 shares during the period. Finally, Vanguard Group Inc lifted its position in UnitedHealth Group by 1.6% during the third quarter. Vanguard Group Inc now owns 69,342,549 shares of the healthcare conglomerate’s stock valued at $18,447,892,000 after purchasing an additional 1,073,505 shares during the period. Institutional investors own 87.29% of the company’s stock.

In other news, Director Gail R. Wilensky sold 2,930 shares of the firm’s stock in a transaction on Thursday, March 14th. The shares were sold at an average price of $253.39, for a total transaction of $742,432.70. Following the sale, the director now directly owns 64,726 shares in the company, valued at approximately $16,400,921.14. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Richard T. Burke sold 5,000 shares of the firm’s stock in a transaction on Tuesday, March 12th. The shares were sold at an average price of $245.01, for a total transaction of $1,225,050.00. Following the sale, the director now owns 182,372 shares in the company, valued at $44,682,963.72. The disclosure for this sale can be found here. Insiders have sold a total of 27,930 shares of company stock worth $6,746,683 over the last 90 days. Insiders own 0.87% of the company’s stock.

A number of research analysts recently weighed in on UNH shares. Credit Suisse Group restated a “buy” rating and set a $310.00 price objective on shares of UnitedHealth Group in a research report on Friday, February 8th. ValuEngine downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Wednesday, February 27th. Zacks Investment Research downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Tuesday, March 19th. SunTrust Banks lowered their price objective on shares of UnitedHealth Group to $300.00 and set a “buy” rating on the stock in a research report on Wednesday, April 17th. They noted that the move was a valuation call. Finally, Raymond James lowered their price objective on shares of UnitedHealth Group from $310.00 to $265.00 and set a “strong-buy” rating on the stock in a research report on Wednesday, April 17th. One analyst has rated the stock with a sell rating, one has assigned a hold rating, nineteen have assigned a buy rating and one has given a strong buy rating to the stock. The stock has an average rating of “Buy” and an average target price of $290.84.

Shares of UNH stock opened at $242.46 on Monday. The firm has a market cap of $229.39 billion, a PE ratio of 18.82, a PEG ratio of 1.29 and a beta of 0.74. UnitedHealth Group Inc has a one year low of $208.07 and a one year high of $287.94. The company has a debt-to-equity ratio of 0.63, a quick ratio of 0.73 and a current ratio of 0.73.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $3.73 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $3.60 by $0.13. The firm had revenue of $60.30 billion for the quarter, compared to the consensus estimate of $59.72 billion. UnitedHealth Group had a net margin of 5.45% and a return on equity of 25.07%. The company’s revenue was up 9.2% on a year-over-year basis. During the same period last year, the firm earned $3.04 EPS. On average, equities analysts forecast that UnitedHealth Group Inc will post 14.7 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This piece was reported by Daily Political and is owned by of Daily Political. If you are viewing this piece on another publication, it was illegally stolen and republished in violation of U.S. and international copyright & trademark laws. The legal version of this piece can be read at https://www.dailypolitical.com/2019/05/20/stone-house-investment-management-llc-acquires-new-stake-in-unitedhealth-group-inc-unh.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Featured Article: What is Elliott Wave theory?

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.